SCHEMBL58479

SCHEMBL58479

[CH2]C(C)(CC)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23355931 1.00
SCHEMBL631310 0.86
SCHEMBL59981 0.81
SCHEMBL3895632 0.79 TSHR (0.37)
SCHEMBL104576 0.78
SCHEMBL7779245 0.78 TSHR (0.33)
SCHEMBL149818 0.78
SCHEMBL3886927 0.77 TSHR (0.42)
SCHEMBL28154755 0.77 TSHR (0.42)
SCHEMBL28153705 0.77 TSHR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3529 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016037223-A1 DIRHODIUM COMPOUNDS AND METHODS OF USE GHANEM ASHRAF (AU) 2016-03-17 WO claimed
US-20130087745-A1 SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS PRECURSOR ENERGETICS, INC. (US) 2013-04-11 US claimed
WO-2006065842-A2 5,6,7,8-TETRAHYDROQUINOLINES AND RELATED COMPOUNDS AND USES THEREOF SYNTA PHARMACEUTICALS CORP. (US) 2006-06-22 WO claimed
EP-1663227-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS Synta Pharmaceuticals Corporation (US) 2006-06-07 EP claimed
US-20050203119-A1 Dihydropyridine compounds for treating or preventing metabolic disorders SYNTA PHARMACEUTICAL CORP. 2005-09-15 US claimed
WO-2005025507-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS SYNTA PHAMACEUTICALS CORP. (US) 2005-03-24 WO claimed
EP-0242801-B1 HYDROCARBYLOXY MAGNESIUM HALIDES LITHIUM CORPORATION OF AMERICA (US) 1993-03-10 EP claimed
US-4792640-A REACTING ACTIVATED MAGNESIUM METAL WITH ALKYL HALIDE, REACTING PRODUCT WITH ALCOHOL LITHIUM CORPORATION OF AMERICA (US) 1988-12-20 US claimed
EP-0242801-A2 Hydrocarbyloxy magnesium halides LITHIUM CORPORATION OF AMERICA (US) 1987-10-28 EP claimed
WO-2024148932-A1 EGFR C797S MUTATION INHIBITOR AND PHARMACEUTICAL USE THEREOF 上海和誉生物医药科技有限公司 2024-07-18 WO disclosed
CN-118344364-A Amino-substituted fused heteroaryl compounds, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-07-16 CN disclosed
CN-118344365-A Condensed heteroaryl compound, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2024-07-16 CN disclosed
CN-113939516-B Methods and compositions for targeting protein degradation 珃诺生物医药科技(杭州)有限公司 2024-07-16 CN disclosed
CN-114845739-B Pharmaceutical conjugate of eribulin derivative, preparation method and application thereof in medicine 上海森辉医药有限公司 2024-07-16 CN disclosed
EP-0818512-A1 Quinoline derivative and use of same MITSUI TOATSU CHEMICALS, Inc. (JP) 1998-01-14 EP disclosed
EP-0737660-A1 Inhibition of unsaturated monomers with 7-aryl quinone methides CIBA-GEIGY AG (CH) 1996-10-16 EP disclosed
EP-0737659-A1 7-Substituted quinone methides as inhibitors for unsaturated monomers CIBA-GEIGY AG (CH) 1996-10-16 EP disclosed
US-4804654-A INSECTICIDES, MITICIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-02-14 US disclosed
CN-86107067-A Weedicide 1987-10-21 CN disclosed
US-3971825-A (5,6) (10,11) BIS-METHYLENE, BRONCHODILATORS SANKYO COMPANY LIMITED (JA) 1976-07-27 US disclosed